Literature DB >> 12477572

Adenosine triphosphate stimulates human osteoclast activity via upregulation of osteoblast-expressed receptor activator of nuclear factor-kappa B ligand.

K A Buckley1, R A Hipskind, A Gartland, W B Bowler, J A Gallagher.   

Abstract

Nucleotides such as adenosine triphosphate (ATP) and uridine triphosphate (UTP) exist in the extracellular environment where they are agonists at P2 receptors. Both P2Y G-protein-coupled receptors and P2X ligand-gated ion channels are expressed by osteoblasts and osteoclasts, reflected in the diverse nucleotide-induced effects reported to occur in bone. Previous reports have implicated ATP as a proresorptive agent; however, these studies were unable to determine whether ATP mediated its actions directly on osteoclasts, or indirectly via osteoblasts. The development of techniques to generate human osteoclasts in vitro has allowed us to further investigate the intriguing role of extracellular nucleotides with regard to osteoclast activity. This study reports that nearly all P2-receptor-subtype mRNAs were expressed throughout human osteoclast development, and provides evidence for functional P2 receptor expression by these cells. In cultures of human osteoclasts alone, neither ATP nor UTP affected the quantity of resorption by these cells; however, in cocultures of osteoblast-like UMR-106 cells and human osteoclasts, ATP, but not UTP, greatly enhanced resorption, indicating a role for osteoblasts in mediating the proresorptive effects of ATP. Furthermore, ATP, but not UTP, elevated receptor activator of nuclear factor-kappaB ligand (RANKL) mRNA and protein expression by UMR-106 cells. These data are consistent with observations that UMR-106 cells predominantly express P2Y(1) with low expression of P2Y(2), thereby explaining the response to ATP and not UTP, and further substantiating the involvement of osteoblasts in ATP-induced effects on osteoclasts. These results significantly advance our understanding of the role of P2 receptors in bone, and indicate that local-acting ATP may play a pivotal role in osteoclast activation at bone-resorbing sites by inducing elevated expression of RANKL.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12477572     DOI: 10.1016/s8756-3282(02)00877-3

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  30 in total

1.  Invited Lectures : Overviews Purinergic signalling: past, present and future.

Authors: 
Journal:  Purinergic Signal       Date:  2006-05-15       Impact factor: 3.765

2.  Dynamic redistribution of paxillin in bovine osteoblasts stimulated with adenosine 5'-triphosphate.

Authors:  Ann-Sophie Silber; Bastian Pfau; Toh Weng Tan; Ralf Jacob; David Jones; Thomas Meyer
Journal:  J Mol Histol       Date:  2012-05-05       Impact factor: 2.611

3.  UTP-induced ATP release is a fine-tuned signalling pathway in osteocytes.

Authors:  Tina M Kringelbach; Derya Aslan; Ivana Novak; Peter Schwarz; Niklas R Jørgensen
Journal:  Purinergic Signal       Date:  2013-12-28       Impact factor: 3.765

Review 4.  Purinergic signalling in the musculoskeletal system.

Authors:  Geoffrey Burnstock; Timothy R Arnett; Isabel R Orriss
Journal:  Purinergic Signal       Date:  2013-08-14       Impact factor: 3.765

5.  Reduced bone turnover in mice lacking the P2Y13 receptor of ADP.

Authors:  Ning Wang; Bernard Robaye; Ankita Agrawal; Timothy M Skerry; Jean-Marie Boeynaems; Alison Gartland
Journal:  Mol Endocrinol       Date:  2011-11-22

6.  The ADP receptor P2RY12 regulates osteoclast function and pathologic bone remodeling.

Authors:  Xinming Su; Desiree H Floyd; Alun Hughes; Jingyu Xiang; Jochen G Schneider; Ozge Uluckan; Emanuela Heller; Hongju Deng; Wei Zou; Clarissa S Craft; Kaiming Wu; Angela C Hirbe; Dorota Grabowska; Mark C Eagleton; Sarah Townsley; Lynne Collins; David Piwnica-Worms; Thomas H Steinberg; Deborah V Novack; Pamela B Conley; Michelle A Hurchla; Michael Rogers; Katherine N Weilbaecher
Journal:  J Clin Invest       Date:  2012-09-17       Impact factor: 14.808

7.  Reversal of loss of bone mass in old mice treated with mefloquine.

Authors:  Rafael Pacheco-Costa; Hannah M Davis; Emily G Atkinson; Julian E Dilley; Innocent Byiringiro; Mohammad W Aref; Matthew R Allen; Teresita Bellido; Lilian I Plotkin
Journal:  Bone       Date:  2018-06-05       Impact factor: 4.398

8.  Selective induction of P2Y14 receptor by RANKL promotes osteoclast formation.

Authors:  Seung Ah Lee; Jin Hee Park; Soo Young Lee
Journal:  Mol Cells       Date:  2013-09-17       Impact factor: 5.034

9.  1alpha,25(OH)(2) vitamin D(3) induction of ATP secretion in osteoblasts.

Authors:  Payal Biswas; Laura P Zanello
Journal:  J Bone Miner Res       Date:  2009-08       Impact factor: 6.741

10.  Expression, signaling, and function of P2X7 receptors in bone.

Authors:  Matthew W Grol; Nattapon Panupinthu; Jasminka Korcok; Stephen M Sims; S Jeffrey Dixon
Journal:  Purinergic Signal       Date:  2009-02-18       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.